It was one of those stressful moments when I simply did what needed to be done. My mother had been visiting us in the city for a couple of weeks, and I was sending her home on the train. Parking here in downtown Toronto is nearly impossible, so my husband…
Soliris (eculizumab) is linked to a reduced relapse rate and stabilization of disability progression in people with neuromyelitis optica spectrum disorder (NMOSD) who test positive for anti-AQP4 antibodies, according to a real-world study in Turkey. “These results support [Soliris] as a valuable therapy for [AQP4-related] NMOSD, while stressing the…
Discussion
It’s unusual for Toronto to be hit by two massive snowfalls in one week, shutting down the city and giving kids rare snow days. As a lifelong Canadian, I’m no stranger to snow, although I’m usually fortunate enough to avoid anything major. The downtown skyscrapers in Toronto usually shield us…
NMOSD is a progressive autoimmune disease where the immune system mistakenly attacks nerve cells, affecting the nervous system. Learn more about the disease here.
Scientists do not know the exact underlying cause of NMOSD. Self-reactive antibodies that target AQP4 are known to play a major role. Learn more about what causes the disease here.
When the disease affects the optic nerve (optic neuritis), it can result in pain inside the eye and possibly blurry vision or vision loss. Learn more about the symptoms of the disease here.
Get regular updates to your inbox.
